Capstone Investment Advisors, LLC Incyte Corp Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 4,300 shares of INCY stock, worth $300,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,300

Previous 1,600 168.75%

Holding current value

$300,312

Previous $96,000 195.83%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $43,914 - $52,555	-766 Reduced 19.6%	3,143 $207,000
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $583,912 - $727,323	-11,409 Reduced 74.48%	3,909 $236,000
Q1 2024 May 01, 2024	BUY	$56.55 - $66.59 $809,230 - $952,902	14,310 Added 1419.64%	15,318 $872,000
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $564,788 - $695,049	-10,828 Reduced 91.48%	1,008 $63,000
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $24,552 - $28,020	-425 Reduced 3.47%	11,836 $683,000
Q2 2023 Aug 10, 2023	BUY	$60.95 - $75.51 $386,118 - $478,355	6,335 Added 106.9%	12,261 $763,000
Q1 2023 May 09, 2023	BUY	$70.23 - $86.01 $416,182 - $509,695	5,926 New	5,926 $428,000
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $326,532 - $408,831	4,934 Added 539.23%	5,849 $390,000
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $60,223 - $75,693	910 Added 18200.0%	915 $70,000
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $3.39 Million - $4.1 Million	-51,378 Reduced 99.99%	5 $0
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $890,117 - $1.04 Million	-14,053 Reduced 21.48%	51,383 $3.77 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $3.38 Million - $4.14 Million	49,240 Added 304.03%	65,436 $0
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $741,113 - $812,190	-9,279 Reduced 36.42%	16,196 $0
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $716,716 - $947,514	9,428 Added 58.75%	25,475 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $1.15 Million - $1.39 Million	14,261 Added 798.49%	16,047 $1.4 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $99,531 - $128,337	1,170 Added 189.94%	1,786 $160,000
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $58,328 - $69,302	-801 Reduced 56.53%	616 $46,000
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $13,674 - $16,498	-186 Reduced 11.6%	1,417 $120,000
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $74,353 - $88,893	-1,271 Reduced 44.22%	1,603 $102,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $177,469 - $213,337	2,874 New	2,874 $199,000
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $224,262 - $272,646	-2,700 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $196,476 - $244,860	-2,100 Reduced 43.75%	2,700 $255,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $523,920 - $663,696	4,800	4,800 $560,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Incyte Corp Transaction History